Actively Recruiting
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Led by Albert Einstein College of Medicine · Updated on 2025-07-22
1000
Participants Needed
1
Research Sites
674 weeks
Total Duration
On this page
Sponsors
A
Albert Einstein College of Medicine
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
CONDITIONS
Official Title
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Has 22q11 deletion of 3 megabases (Mb)
You will not qualify if you...
- Has 22q11 deletion smaller than 3 Mb or no deletion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Albert Einstein College of Medicine
New York, New York, United States, 10461
Actively Recruiting
Research Team
B
Bernice E. Morrow, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here